It could pursue formal rulemaking, announce an interim enforcement position, request more information, narrow conditions, or take another approach within its authority
Long-term safety, heart-and-blood-vessel outcomes, rare events, and what happens after stopping are still unknown - these are the questions Phase 3 is built to answer
Rotate the injection site each day to prevent irritation and lipohypertrophy
If you sit at a desk, you may be able to go back sooner
Many trials report overall efficacy but lack adequate power or pre-specified plans to detect sex differences (Raparelli et al., 2020)
Most clinical pathways look like this: Diagnose OSA with a sleep test (home or in-lab) Start CPAP for immediate symptom relief and cardiovascular protection Concurrently start tirzepatide if the patient qualifies and wants weight loss After 6 to 12 months, repeat the sleep study to measure new AHI If AHI is below 5, consider weaning off CPAP under physician supervision Some patients reach normal AHI on tirzepatide alone and stop CPAP